FDA clears deep transcranial magnetic stimulation device to treat obsessive-compulsive disorder

Brain­sWay’s Brain Stim­u­la­tion Device Receives FDA Approval to Treat Obses­­sive-Com­pul­­sive Dis­or­der (IEEE Spec­trum): “In 2013, Jerusalem-based Brain­sWay began mar­ket­ing a new type of brain stim­u­la­tion device that uses mag­net­ic puls­es to treat major depres­sive dis­or­der. Now, thanks to pos­i­tive results in a study of 100 patients, the com­pa­ny has received approval from the U.S. Food…

Read More